A detailed history of Davis Investment Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Davis Investment Partners, LLC holds 12,804 shares of BMY stock, worth $599,355. This represents 0.24% of its overall portfolio holdings.

Number of Shares
12,804
Previous 12,941 1.06%
Holding current value
$599,355
Previous $614 Million 11.52%
% of portfolio
0.24%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 06, 2026

SELL
$42.6 - $49.08 $5,836 - $6,723
-137 Reduced 1.06%
12,804 $684 Million
Q3 2025

Oct 20, 2025

SELL
$43.31 - $48.98 $54,613 - $61,763
-1,261 Reduced 8.88%
12,941 $614 Million
Q2 2025

Jul 08, 2025

SELL
$44.12 - $59.6 $133,330 - $180,111
-3,022 Reduced 17.55%
14,202 $675 Million
Q1 2025

Apr 15, 2025

BUY
$53.9 - $63.11 $534,256 - $625,546
9,912 Added 135.56%
17,224 $884 Million
Q4 2024

Jan 13, 2025

BUY
$51.92 - $59.94 $379,639 - $438,281
7,312 New
7,312 $408 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Davis Investment Partners, LLC Portfolio

Follow Davis Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davis Investment Partners, LLC with notifications on news.